Hemorrhagic bullous lichen sclerosus

Authors

  • Aldana Assad General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina
  • Tatiana Delaloye General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina
  • Mayled Delgado General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina
  • Eliana Gerez General San Martín Interzonal General Acute Hospital, La Plata, Province of Buenos Aires, Argentina
  • Gabriela Arena General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina

DOI:

https://doi.org/10.47196/da.v31i3.2963

Keywords:

lichen sclerosus, bullous lichen sclerosus, extragenital lichen sclerosus

Abstract

Lichen sclerosus is a chronic inflammatory mucocutaneous disease that primarily affects the anogenital area in 85% of cases. Extragenital lichen sclerosus is most prevalent in women between their fifth and sixth decades of life. Clinically, it usually manifests as whitish papules that cluster together to form well-defined plaques; they are generally asymptomatic, although they may be itchy. Blistering and hemorrhagic presentations are rare. Diagnosis requires histopathological examination, and first-line treatment includes topical corticosteroids. We present a case seen in our Department.

Author Biographies

Aldana Assad, General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina

Second-year Dermatology Resident

Tatiana Delaloye, General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina

First-year Resident Physician in Dermatology

Mayled Delgado, General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina

Third-year Dermatology Resident

Eliana Gerez, General San Martín Interzonal General Acute Hospital, La Plata, Province of Buenos Aires, Argentina

Staff Physician of the Dermatology Service

Gabriela Arena, General San Martín Interzonal General Acute Hospital, La Plata, Buenos Aires Province, Argentina

Head of the Dermatology Service

References

I. Khatu S, Vasani R. Isolated, localised extragenital bullous lichen sclerosus et atrophicus: a rare entity. Indian J Dermatol. 2013;58:409.

II. De Luca DA, Papara C, Vorobyev A, Staiger H, ét al. Lichen sclerosus: the 2023 update. Front Med (Lausanne). 2023;10:1106318.

III. Arif T, Fatima R, Sami M. Extragenital lichen sclerosus: a comprehensive review. Australas J Dermatol. 2022;63:452-462.

IV. Lima RSA, Maquiné GA, Schettini APM, Santos M. Bullous and hemorrhagic lichen sclerosus. Case report. An Bras Dermatol. 2015;90:S118-20.

V. Khatib J, Wargo JJ, Krishnamurthy S, Travers JB. Hemorrhagic bullous lichen sclerosus: a case report. Am J Case Rep. 2020 Oct 7;21:e919353.

VI. López-Bertrán JM, FM Renis, MH Stefanazzi, C Simionato, ét al. Liquen escleroso extra genital ampollar y hemorrágico: a propósito de un caso. Rev Argent Dermatol. 2010; 91:51-60.

VII. Liu L, Zhan Y, Shi Y, Zeng Z, Yu J, ét al. Bullous lichen sclerosus-generalized morphea overlap syndrome improved by tofacitinib. Dermatol Ther. 2022 Dec;35:e15942.

VIII. Zundell MP, Al-Dehneem R, Song T, Yousif J, Gottlieb AB. Novel clinical applications of topical ruxolitinib: a case series. J Drugs Dermatol. 2024 Mar 1;23:188-190.

Published

2025-12-01

Issue

Section

Clinical Cases